Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Schiffman

Showing results (31-40 of 498) with videos related to

Pageof 50
Sort By:
The New England Journal of Medicine|February 7, 2003
Adding a test for human papillomavirus DNA to cervical-cancer screeningThomas C Wright, Mark Schiffman
The New England Journal of Medicine|November 18, 2005
The promise of global cervical-cancer preventionMark Schiffman, Philip E Castle
BMJ (Clinical Research Ed.)|January 18, 2006
When to test women for human papillomavirusMark Schiffman, Philip E Castle
Preventive Medicine|February 18, 2018
A novel metric that quantifies risk stratification for evaluating diagnostic tests: The example of evaluating cervical-cancer screening tests across populationsHormuzd A Katki, Mark Schiffman
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 23, 2016
Sholom Wacholder: In Memoriam (1955-2015)Mark Schiffman, Robert D Burk
The Lancet. Oncology|May 3, 2008
Heterogeneity in CIN3 diagnosisMark Schiffman, Ana Cecilia Rodríguez
Lancet (London, England)|August 3, 2024
The rational design of cervical cancer prevention strategiesMark Schiffman, Silvia de Sanjose
Obstetrics and Gynecology|June 1, 2002
ASCUS LSIL Triage Study (ALTS) conclusions reaffirmed: response to a November 2001 commentaryDiane Solomon, Mark Schiffman, Robert Tarone
Sexually Transmitted Diseases|September 24, 2009
The use of human papillomavirus seroepidemiology to inform vaccine policyMark Schiffman, Mahboobeh Safaeian, Nicolas Wentzensen
JAMA|December 5, 2023
Primary HPV Screening vs Cotesting for Cervical Cancer-ReplyRebecca B Perkins, Nicolas Wentzensen, Mark Schiffman
Pageof 50

Showing results (31-40 of 498) with videos related to

Sort By:
Pageof 50
The New England Journal of Medicine|February 7, 2003
Adding a test for human papillomavirus DNA to cervical-cancer screeningThomas C Wright, Mark Schiffman
The New England Journal of Medicine|November 18, 2005
The promise of global cervical-cancer preventionMark Schiffman, Philip E Castle
BMJ (Clinical Research Ed.)|January 18, 2006
When to test women for human papillomavirusMark Schiffman, Philip E Castle
Preventive Medicine|February 18, 2018
A novel metric that quantifies risk stratification for evaluating diagnostic tests: The example of evaluating cervical-cancer screening tests across populationsHormuzd A Katki, Mark Schiffman
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 23, 2016
Sholom Wacholder: In Memoriam (1955-2015)Mark Schiffman, Robert D Burk
The Lancet. Oncology|May 3, 2008
Heterogeneity in CIN3 diagnosisMark Schiffman, Ana Cecilia Rodríguez
Lancet (London, England)|August 3, 2024
The rational design of cervical cancer prevention strategiesMark Schiffman, Silvia de Sanjose
Obstetrics and Gynecology|June 1, 2002
ASCUS LSIL Triage Study (ALTS) conclusions reaffirmed: response to a November 2001 commentaryDiane Solomon, Mark Schiffman, Robert Tarone
Sexually Transmitted Diseases|September 24, 2009
The use of human papillomavirus seroepidemiology to inform vaccine policyMark Schiffman, Mahboobeh Safaeian, Nicolas Wentzensen
JAMA|December 5, 2023
Primary HPV Screening vs Cotesting for Cervical Cancer-ReplyRebecca B Perkins, Nicolas Wentzensen, Mark Schiffman
Pageof 50